SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-22-023755
Filing Date
2022-08-22
Accepted
2022-08-22 17:09:04
Documents
12
Period of Report
2022-08-22
Items
Item 4.02: Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 34777
  Complete submission text file 0001493152-22-023755.txt   201175

Data Files

Seq Description Document Type Size
2 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mslp-20220822.xsd EX-101.SCH 2980
3 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mslp-20220822_lab.xml EX-101.LAB 34240
4 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mslp-20220822_pre.xml EX-101.PRE 22373
6 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3285
Mailing Address 4721 IRONTON STREET DENVER CO 80239
Business Address 4721 IRONTON STREET DENVER CO 80239 (800) 210-7369
MusclePharm Corp (Filer) CIK: 0001415684 (see all company filings)

IRS No.: 770664193 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-53166 | Film No.: 221184427
SIC: 2834 Pharmaceutical Preparations